Revvity, Inc. today announced the development of the T-SPOTâ„¢ A201, a next-generation high-throughput automated platform ...
MarketsandMarketsâ„¢ projects the global high-throughput screening (HTS) market will grow from USD 27.66 billion in 2026 to USD ...
Molecular Devices developed an end-to-end, automated workflow, beginning with assay-ready colorectal cancer organoids, comprising establishment in culture, maintenance, and screening. Automation ...
Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.
High-throughput screening (HTS) is a cornerstone of modern drug discovery, enabling the evaluation of thousands to millions of potential drug compounds. Advances in automation and miniaturization have ...